Comparative Trial of Pancrex V Forte and Nutrizym in Treatment of Malabsorption in Cystic Fibrosis

Goodchild, Mary C.; Sagaró, E.; Brown, G. A.; Cruchley, Patricia M.; Jukes, Hilda R.; Anderson, Charlotte M.
September 1974
British Medical Journal;9/21/1974, Vol. 3 Issue 5933, p712
Academic Journal
No abstract available.


Related Articles

  • Cystic Fibrosis.  // Current Medical Literature: Respiratory Medicine;2008, Vol. 22 Issue 1, p18 

    The article presents abstracts of research related to cystic fibrosis published in various journals including the "Effect of Albuterol on Maximal Exercise Capacity in Cystic Fibrosis," "Randomized Placebo Controlled Trial of Non-invasive Ventilation for Hypercapnia in Cystic Fibrosis," and...

  • CF: Not just a pediatric problem anymore. George, Maureen Redmond; Mauro, Elizabeth // RN;Sep90, Vol. 53 Issue 9, p60 

    Discusses the care and support available for adults with cystic fibrosis. Average age of survival for cystic fibrosis patients; Complications of cystic fibrosis; Treatment for cystic fibrosis.

  • The enzyme knife-a renewed direction for cancer therapy? Discussion paper. Richards, B. A. // Journal of the Royal Society of Medicine;May1988, Vol. 81 Issue 5, p284 

    The article focuses on the renewed techniques for cancer therapy. The trophoblast theory of embryologist John Beard that was published in his paper "The Trophoblast Theory of Cancer" has led to the re-introduction of simple methodology for cancer therapy. These include Pancrex V Forte treatment...

  • Escherichia coli Dysbiosis Correlates With Gastrointestinal Dysfunction in Children With Cystic Fibrosis. Hoffman, Lucas R.; Pope, Christopher E.; Hayden, Hillary S.; Heltshe, Sonya; Levy, Roie; McNamara, Sharon; Jacobs, Michael A.; Rohmer, Laurence; Radey, Matthew; Ramsey, Bonnie W.; Brittnacher, Mitchell J.; Borenstein, Elhanan; Miller, Samuel I. // Clinical Infectious Diseases;Feb2014, Vol. 58 Issue 3, p396 

    Cystic fibrosis gastrointestinal disease includes nutrient malabsorption and intestinal inflammation. We show that the abundances of Escherichia coli in fecal microbiota were significantly higher in young children with cystic fibrosis than in controls and correlated with fecal measures of...

  • US trial of gene therapy for cystic fibrosis. Tanne, Janice Hopkins // BMJ: British Medical Journal (International Edition);04/24/99, Vol. 318 Issue 7191, p1096 

    Reports that researchers at Stanford University Medical Center in California have started a trial of gene therapy delivered by aerosol to the lungs of patients with cystic fibrosis. Details on the treatment; Information on the spread of cystic fibrosis in the United States and the United Kingdom.

  • Can Curcumin Cure Cystic Fibrosis? Zeitlin, Pamela // New England Journal of Medicine;8/5/2004, Vol. 351 Issue 6, p606 

    Offers a look at research into treatments for cystic fibrosis as of August 2004. Statement that cystic fibrosis is a progressive and fatal inherited disorder caused by a mutant cystic fibrosis transmembrane conductance regulator; Reference to a medical study on curcumin, a nutraceutical agent,...

  • Antenatal screening for carriers of cystic fibrosis: Randomised trial of stepwise ... couple... Miedzybrodzka, Zosia H.; Hall, Marion H. // BMJ: British Medical Journal (International Edition);2/11/95, Vol. 310 Issue 6976, p353 

    Presents a comparative evaluation of stepwise and couple approaches to antenatal carrier screening for cystic fibrosis. Pragmatic randomized trial of 2,002 women in a hospital antenatal clinic; Counseling and carrier testing for cystic fibrosis; Uptake rates, anxiety, knowledge of cystic...

  • Novel Pharmaceutical Approaches for Treating Patients with Cystic Fibrosis. Saeed, Z.; Wojewodka, G.; Marion, D.; Guilbault, C.; Radzioch, D. // Current Pharmaceutical Design;Nov2007, Vol. 13 Issue 31, p3252 

    Before the cloning of the CFTR gene in 1989, there were relatively few treatment options for the many phenotypes associated with cystic fibrosis (CF). The advancement of research in areas such as immunology, molecular biology and pharmacology have provided new insights into the mechanism and...

  • Vitamin E deficiency and neurologic disease in adults with cystic fibrosis. Sitrin, Michael D.; Lieberman, Frank; Jensen, Wesley E.; Noronha, Avertano; Milburn, Carol; Addington, Whitney; Sitrin, M D; Lieberman, F; Jensen, W E; Noronha, A; Milburn, C; Addington, W // Annals of Internal Medicine;Jul87, Vol. 107 Issue 1, p51 

    We report the cases of two adult patients with cystic fibrosis affecting the pancreas and liver, who also had severe vitamin E deficiency and neurologic disease. The most prominent clinical features were abnormal eye movements, diminished reflexes, decreased vibratory and position sense, ataxia,...

  • Hospital-associated hyponatremia. Anderson, Robert J. // Kidney International;Jun1986, Vol. 29 Issue 6, p1237 

    Reports on the case of an 18-year-old woman with cystic fibrosis who was admitted to the hospital for evaluation of shortness of breath and a productive cough of one week duration. Documentation of fat malabsorption and an elevated sweat chloride concentration; Treatment of the patient with...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics